Job Description

Key Information

Salary

: 31,445 - 33,100 Commencement on the salary range is subject to comparable skills and experience.

Reporting to:

Charlotte Pawlyn

Duration of Contract

: Fixed Term for 12 months

Hours per week

35 hours per week (Full Time)

Location:

Sutton

Closing Date

31/10/25

Job Details

Under the guidance of Dr Chalotte Pawlyn, we are seeking to recruit a Scientific Officer to contribute to our work understanding mechanisms of resistance to therapies used to treat the bone marrow cancer myeloma. The successful candidate will play a key role in the isolation of myeloma cells from patient samples and downstream processing, experiments and storage. Additionally the SO will support a range of ongoing molecular and cell biology experiments using cell lines and primary samples within the team, including cell viability assays, flow cytometry, qPCR and Western blotting. There will be opportunities to gain experience in novel techniques and explore new avenues of research.

About you

The successful candidate must have:


A degree in a biological science Proficiency in cell culture and a range of cell/molecular biology techniques Enthusiasm to work in an interdisciplinary environment towards the goal of developing improved cancer therapeutics

Department/Directorate Information

Myeloma Biology and Therapeutics Group



Dr Charlotte Pawlyn's team Myeloma Biology and Therapeutics focuses on identifying and validating therapeutic targets for the treatment of immunomodulatory drug resistant and high-risk multiple myeloma. Myeloma is a bone marrow cancer and the second most common haematological malignancy. Immunomodulatory drugs are the "prototype" of targeted protein degradation approaches. Outcomes for patients have improved over the last few decades following the introduction of proteasome inhibitors and immunomodulatory agents. However, patients almost all inevitably relapse and understanding the mechanisms of resistance to these commonly used agents is key to improving outcomes.


The team sits within the Division of Cancer Therapeutics which has an unrivalled track record at discovering novel cancer treatments and biomarkers. Their work has made The Institute of Cancer Research the world's most successful academic centre at discovering new cancer drugs. We also work closely with the Centre of Protein Degradation

What we offer

A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Charlotte Pawlyn via Email on Charlotte.Pawlyn@icr.ac.uk

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.



The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.



The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

At the Institute of Cancer Research, we champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

Don't let a checklist of qualifications hold you back - if you're passionate about the role, we want to hear from you. Your unique experiences and backgrounds contribute to the richness of our team. We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.